Benefits of antithrombotic therapy after infrainguinal bypass grafting: A meta-analysis

American Journal of Medicine

Volumn 117, Issue 2, 2004, Pages 93-99

  Collins, Tracie C ^a   Souchek, Julianne ^a   Beyth, Rebecca J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; COUMARIN; DIPYRIDAMOLE; PHENPROCOUMON; TICLOPIDINE;

ARTICLE; BLEEDING; BLOOD VESSEL GRAFT; BYPASS SURGERY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONFIDENCE INTERVAL; FIBRINOLYTIC THERAPY; GRAFT OCCLUSION; GRAFT PATENCY; HEART INFARCTION; HUMAN; LEG; MEDLINE; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZATION; THROMBOSIS;

FIBRINOLYTIC AGENTS; GRAFT OCCLUSION, VASCULAR; HUMANS; LOWER EXTREMITY; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; SAPHENOUS VEIN; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 3242695013     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2003.12.042     Document Type: Article

References (29)

1. Dormandy J., Thomas P. What is the natural history of a critically ischemic patient with and without his leg? Greenhalgh R., Jamieson C. Limb Salvage and Amputation for Vascular Disease. 1988;11-26 W.B. Saunders, Philadelphia, Pennsylvania
2. Morise A., McDowell D., Savrin R., et al. The prediction of cardiac risk in patients undergoing vascular surgery. Am J Med Sci. 293:1987;150-158
3. Farkouh M., Rihal C., Gersh B., et al. Influence of coronary heart disease on morbidity and mortality after lower extremity revascularization surgery a population-based study in Olmsted County, Minnesota (1970-1987). J Am Coll Cardiol. 24:1994;1290-1296
4. Ascer E., Collier P., Gupta S., Veith F. Reoperation for PTFE bypass failure importance of distal outflow site and operative techniques in determining outcome. J Vasc Surg. 5:1987;298-310
5. Veith F., Gupta S., Ascer E., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal internal reconstructions. J Vasc Surg. 3:1986;104-114
6. Olin JW. Clinical evaluation and office-based detection of peripheral arterial disease. In: Hirsch AT, Olin FW, eds. An Office-Based Approach to the Diagnosis and Treatment of Peripheral Arterial Disease. Part I. The Epidemiology and Practical Detection of PAD. Am J Med [Continuing Medical Education Series]. 1998:10-17
7. Jackson M., Clagett G. Antithrombotic therapy in peripheral arterial occlusive disease. Chest. 114:(suppl):1998;666S-682S
8. Hagen P., Wang Z., Mikat E., et al. Antiplatelet therapy reduces aortic intimal hyperplasia distal to small-diameter vascular prostheses (PTFE) in nonhuman primates. Ann Surg. 195:1982;328-339
9. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188
10. Breslow N., Day N. Statistical Methods in Cancer Research. 1980;142 International Agency for Research on Cancer (IARC Scientific Publications), Lyon, France
11. Begg C., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1994;1088-1101
12. Donaldson D., Salter M., Rajah S., et al. The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts. Vasc Surg. 19:1985;224-230
13. Goldman M., McCollum C. A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popliteal grafts. Vasc Surg. 18:1984;217-221
14. Harjola P., Meurala H., Frick M. Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. J Cardiovasc Surg. 22:1981;144
15. Kretschmer G., Wenzl E., Wagner O., et al. Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease. Br J Surg. 73:1986;689-692
16. Satiani B. A prospective randomized trial of aspirin in femoral popliteal and tibial bypass grafts. Angiology. 36:1985;608-616
17. Arfvidsson B., Lundgren F., Drott C., et al. Influence of coumarin treatment on patency and limb salvage after peripheral arterial reconstructive surgery. Am J Surg. 159:1990;556-560
18. Becquemin J.P. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. Etude de la Ticlopidine apres Pontage Femoro-Poplite and the Association Universitaire de Recherche en Chirurgie. N Engl J Med. 337:1997;1726-1731
19. Kretschmer G., Herbst F., Prager M., et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg. 127:1992;1112-1115
20. Lassila R., Lepantalo M., Lindfors O. The effect of acetylsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking. World J Surg. 15:1991;378-382
21. McCollum C., Alexander C., Kenchington G., et al. Antiplatelet drugs in femoropopliteal vein bypasses a multicenter trial. J Vasc Surg. 13:1991;150-161
22. Collaborative overview of randomised trials of antiplatelet therapy - II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ. 1994308:159-168
23. Efficacy of oral anticoagulants compared with aspirin after infrain-guinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet. 2000;355:346-351
24. Edmondson R., Cohen A., Das S., et al. Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet. 344:1994;914-918
25. Kohler T.R., Kaufman J.L., Kacoyanis G., et al. Effect of aspirin and dipyridamole on the patency of lower extremity bypass grafts. Surgery. 96:1984;462-466
26. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 286:2001;1317-1324
27. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 326:1992;381-386
28. Collins T., Petersen N., Suarez-Almazor M., Ashton C. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 163:2003;1469-1474
29. McDermott M., Hahn E., Greenland P., et al. Atherosclerotic risk factor reduction in peripheral arterial disease results of a national physician survey. J Gen Intern Med. 17:2002;895-904